Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLESENCE, INC. Director's Dealing 2005

Sep 29, 2005

33563_dirs_2005-09-29_129086fd-7368-40d6-8949-8856fac66cdc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES CORPORATION (NANX)
CIK: 0000883107
Period of Report: 2005-09-27

Reporting Person: LUDWIG EDWARD G JR (VP Business Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-09-27 Common Stock A 1200 Acquired 1200 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2005-09-27 Stock Option (right to buy) $6.03 A 9000 Acquired 2015-09-27 Common Stock (9000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2700 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $5.55 2014-10-11 Common Stock (10000) 10000 Direct
Stock Option (right to buy) $3.66 2013-03-24 Common Stock (10000) 10000 Direct

Footnotes

F1: Subject to certain restrictions, beginning on this date, options vest in five equal annual installments.

F2: Issued pursuant to a restricted share grant under the Company's 2004 Equity Compensation Plan.

F3: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.